Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Tashiro

Showing results (1-10 of 256) with videos related to

Pageof 26
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 18, 2010
[Current situation in human infections with highly pathogenic avian influenza viruses]Masatsugu Obuchi, Masato Tashiro
Medical Mycology Journal|September 2, 2016
The Current Status of Drug-resistant AspergillusMasato Tashiro, Koichi Izumikawa
Medical Mycology Journal|December 1, 2017
[Survival Strategies of Aspergillus in the Human Body]Masato Tashiro, Koichi Izumikawa
Human Vaccines|February 16, 2011
Cross-protective immunity against influenza virus infections induced by intranasal vaccination together with a TLR3-mucosal adjuvantAkira Ainai, Masato Tashiro, Hideki Hasegawa
Therapeutic Advances in Infectious Disease|June 20, 2024
Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challengesMasato Tashiro, Takahiro Takazono, Koichi Izumikawa
Medical Mycology Journal|November 29, 2023
Invasive Malassezia InfectionsMasato Tashiro, Takahiro Takazono, Koichi Izumikawa
Annals of the New York Academy of Sciences|December 13, 2012
Management of chronic pulmonary aspergillosisKoichi Izumikawa, Masato Tashiro, Shigeru Kohno
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2005
Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8Minoru Kidokoro, Masato Tashiro, Hisatoshi Shida
Medical Mycology Journal|December 1, 2024
Overview of Fungi Classified as Risk Group 3 by the Japanese Society for Medical MycologyMasato Tashiro, Takahiro Takazono, Koichi Izumikawa
Frontiers in Medicine|January 3, 2022
Impact of Plasma 5 Hydroxyindoleacetic Acid, a Serotonin Metabolite, on Clinical Severity in Acute Respiratory Distress SyndromeTakeshi Tanaka, Masahiko Mori, Masato Tashiro, et al.
Pageof 26

Showing results (1-10 of 256) with videos related to

Sort By:
Pageof 26
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 18, 2010
[Current situation in human infections with highly pathogenic avian influenza viruses]Masatsugu Obuchi, Masato Tashiro
Medical Mycology Journal|September 2, 2016
The Current Status of Drug-resistant AspergillusMasato Tashiro, Koichi Izumikawa
Medical Mycology Journal|December 1, 2017
[Survival Strategies of Aspergillus in the Human Body]Masato Tashiro, Koichi Izumikawa
Human Vaccines|February 16, 2011
Cross-protective immunity against influenza virus infections induced by intranasal vaccination together with a TLR3-mucosal adjuvantAkira Ainai, Masato Tashiro, Hideki Hasegawa
Therapeutic Advances in Infectious Disease|June 20, 2024
Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challengesMasato Tashiro, Takahiro Takazono, Koichi Izumikawa
Medical Mycology Journal|November 29, 2023
Invasive Malassezia InfectionsMasato Tashiro, Takahiro Takazono, Koichi Izumikawa
Annals of the New York Academy of Sciences|December 13, 2012
Management of chronic pulmonary aspergillosisKoichi Izumikawa, Masato Tashiro, Shigeru Kohno
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2005
Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8Minoru Kidokoro, Masato Tashiro, Hisatoshi Shida
Medical Mycology Journal|December 1, 2024
Overview of Fungi Classified as Risk Group 3 by the Japanese Society for Medical MycologyMasato Tashiro, Takahiro Takazono, Koichi Izumikawa
Frontiers in Medicine|January 3, 2022
Impact of Plasma 5 Hydroxyindoleacetic Acid, a Serotonin Metabolite, on Clinical Severity in Acute Respiratory Distress SyndromeTakeshi Tanaka, Masahiko Mori, Masato Tashiro, et al.
Pageof 26